The CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial (vol 394, pg 1713, 2019) (2019)

First Author: Roberts Ian

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by MRC

No abstract provided

Type: Journal Article/Review

Volume: 394

Parent Publication: LANCET

Issue: 10210

ISSN: 0140-6736